Food & Food Contact Materials
CIRS Group
Chemicals
Food
Cosmetic
Medical Devices
Agrochemicals
Biocides
Carbon Neutrality
Testing
Search

U.S. FDA Color Additive Petition (CAP)

Unlike food ingredients, color additives do not have a GRAS pathway in the United States. The provisions of the FD&C Act that exempt certain food substances from premarket approval based on GRAS status do not apply to color additives. In other words, any substance that meets the definition of a color additive and is not otherwise exempt must obtain authorization through a CAP before being marketed for the intended use. Once approved, the authorization is published in the Federal Register and codified in the CFR, providing publicly verifiable regulatory support for global customers and regulatory authorities.

1. What Is a Color Additive?

A color additive refers to any dye, pigment, or other substance made by a synthetic process or similar process, or extracted, isolated, or otherwise derived from plants, animals, minerals, or other sources, regardless of whether it has undergone any intermediate or final change in characteristics, which, when added or applied to food, drugs, cosmetics, or medical devices, is capable of imparting color thereto.

Exemptions

Food ingredients that inherently have color: Cherries, green or red peppers, chocolate, and orange juice may naturally impart color when mixed with other foods. When the ingredient is not added for the purpose of coloring the product, it is generally not considered a color additive.

Non-coloring uses: A substance used solely for a purpose other than coloring, where its color effect is clearly insignificant to the marketability of the product, is not subject to color additive premarket approval requirements.

2. Two Regulatory Categories of Color Additives: Certified vs. Exempt from Certification

Once approved through a CAP, color additives are generally placed into one of two regulatory categories depending on whether they are subject to batch certification.

Category

Applicable Regulations

Sources and Characteristics

Certification Requirements

Certified

21 CFR Parts 74 and 82

Primarily synthetic organic dyes, lakes, and pigments, including azo, xanthene, triphenylmethane, indigoid and other classes; generally characterized by strong coloring power, uniform color, and relatively low cost

Each batch must undergo FDA certification before the color additive may be used in products for commercial distribution

Exempt from certification

21 CFR Part 73

Primarily derived from natural sources such as plants, minerals, or animals, including cochineal extract/carmine and their lakes; commonly referred to as natural colors

No batch-by-batch FDA certification is required, but users must ensure that each batch complies with applicable identity, purity, specification, and use requirements

3. What are the Requirements for CAP Submission

21 CFR Part 71 establishes the regulatory framework for color additive petitions. Section 71.1(c) specifies the information and data that a petition should contain. In conjunction with FDA’s guidance on the submission of chemical and technical data for color additive petitions, CIRS has summarized the key CAP submission requirements as follows:

No.

Information Element

Description

1

Identity and composition of the color additive

Name; chemical name; chemical structure; molecular weight; composition; source; specifications for individual components; and identification and limits of reaction by-products and impurities

2

Physicochemical and biological properties

Melting point, refractive index, solubility, spectral characteristics (UV/visible absorption), and other relevant properties

3

Product specifications and analytical methods

Analytical reports for multiple batches (at least five batches), including analytical methods and validation data for each specification parameter

4

Manufacturing process

Complete process description and parameters, including time, temperature, pH, etc.; equations for principal and side reactions; list of raw materials and processing aids with common and chemical names; facilities and control measures; and information on third-party manufacturers, where applicable

5

Stability data

Data establishing identity, strength, quality, and purity, including shelf life and relevant packaging and labeling considerations

6

Proposed uses and use levels

Proposed addition levels, expected coloring effects, directions/recommendations/precautions for use, and proposed labeling

7

Data demonstrating the intended effect

Data demonstrating that the color additive achieves the intended coloring effect under the proposed conditions of use

8

Estimated exposure under the proposed uses

Estimated consumption, cumulative dietary exposure, and exposure to chemically related substances

9

Methods of analysis

Qualitative and quantitative methods for determining the color additive in foods, as well as methods for identifying and determining substances formed in foods following use of the color additive

10

Safety studies and complete study reports

Adequate animal studies, generally including biological studies, and other relevant studies; studies should comply with applicable GLP (21 CFR Part 58), IRB (21 CFR Part 56), and informed consent (21 CFR Part 50) requirements, as applicable

11

Proposed tolerances

Proposed tolerance levels and other limitations on use, where necessary

12

Labeling

Proposed label specimens and related explanations

13

Environmental assessment

Depending on the circumstances, a categorical exclusion statement or a complete Environmental Assessment

14

Samples

FDA may request samples from five batches, including batches used in toxicological studies, together with corresponding analytical reports

15

Certification status statement

If exemption from batch certification is requested, the petitioner should explain why batch certification is considered unnecessary

4. Studies and Testing Involved in a CAP

No.

Study/Report

Notes

1

Product specification testing report, including raw data

At least five batches

2

Stability study data

Evaluation of stability under different environmental conditions. If the color additive has established stability characteristics or previous studies have demonstrated its stability, relevant literature and a supporting discussion may be sufficient

3

Method validation for quantitative analytical methods

4

Toxicological study reports, including complete raw data

Studies should be conducted in laboratories compliant with U.S. GLP requirements, with reference to applicable OECD Test Guidelines and the toxicological principles and recommendations in FDA's Redbook 2000

5. Application Procedure and Timeline

Statutory FDA Procedure

  • Within 15 days after submission: FDA notifies the petitioner in writing whether the petition has been filed/accepted for review.
  • Within 30 days after filing: FDA publishes a Notice of Filing in the Federal Register, disclosing the petitioner and a summary of the proposal.
  • Statutory review period: 90 days from filing. If FDA determines that additional time is needed, it may provide written notice extending the review period, up to a maximum of 180 days after filing.
  • Requests for additional information or samples: The 90-day period may be extended accordingly while FDA is awaiting requested information or samples. If the petitioner fails to respond within 180 days after receiving a request, the petition may be considered withdrawn.
  • Submission of substantial new data: If the petitioner submits substantial new information or data, the submission may be treated as a new petition, with the review period restarting.
  • After approval: FDA publishes a Final Rule in the Federal Register. The final rule for a color additive generally becomes effective 31 days after publication and is codified in the CFR, typically under 21 CFR Part 73 or Part 74.

Actual Review Timeline

FDA guidance indicates that review of a CAP may take 180 days or longer. According to FDA materials addressing petition review, direct food additive petitions may take approximately 24 months on average from submission to publication of a final rule. Color additive petitions can vary substantially depending on the scope and complexity of the petition and the number of rounds of supplemental information requested by FDA. Based on CIRS's experience with recently approved cases, the period from submission to approval for color additives is commonly more than three years. Early planning of studies and preparation of the submission package is therefore critical.

Implementation and Estimated Timeline Based on CIRS Experience

Stage

Estimated Timeline

Description

Data gap analysis

1–2 months

Conduct a gap assessment and prepare a customized checklist; FDA pre-submission consultation may be initiated in parallel

FDA pre-submission consultation

Approximately 3–6 months after request, depending on FDA scheduling

Discuss proposed study protocols and adequacy of supporting data

Conduct of studies

1–2 years

Primarily determined by the longest toxicological study

Preparation of CAP dossier

3–6 months

Dossier preparation can proceed in parallel with testing

CAP submission

1–2 months

Submission organized through Form FDA 3503

FDA filing and assignment of CAP number

Approximately 1–3 months, depending on FDA

Notice of Filing subsequently published in the Federal Register

FDA review and rulemaking

1–3 years

Supplemental questions and additional data requests may arise during review

FDA regulatory update

Depending on FDA

Final rule becomes effective and the color additive is codified under 21 CFR Part 73 or Part 74

6. Fee Structure

FDA Fees — Color Additive Petition-Specific Fee Mechanism

Circumstance

Fee

New CAP submission

US$3,000 (FDA may refund part of the fee if the petition is withdrawn)

Expansion of use or use level

US$1,800

Other circumstances, such as a request for a public hearing

US$250–5,000 deposit (e.g., US$250 public hearing application fee)

7. Color Additive Cases Approved Since 2021

According to CIRS statistics, FDA approved 13 color additive petitions since 2021, including 2 approvals in 2026, 5 in 2025, none in 2024, 1 in 2023, 3 in 2022, and 2 in 2021. The time from submission to approval has generally exceeded three years, demonstrating the lengthy review timelines and high data requirements associated with color additive petitions.

CAP No.

Substance

Application Year

First Final Rule

Latest Final Rule

Category

CAP 4C0326

Beetroot Red

2023

2026/02/06

2026/03/24 (delayed effective date)

New color additive

CAP 4C0334

Spirulina Extract

2024

2026/02/06

2026/03/24 (delayed effective date)

Expansion of use

CAP 1C0319

Gardenia Blue (Genipin Blue)

2021

2025/07/15

2025/10/01

New color additive

CAP 4C0328

Butterfly Pea Flower Extract

2023

2025/05/12

2025/08/21

Expansion of use

CAP 1C0320

Spirulina Extract

2021

2025/05/12

2025/08/21

New color additive

CAP 3C0324

Calcium Phosphate

2023

2025/05/12

2025/08/21

New color additive

CAP 2C0322

Myoglobin

2021

2025/01/17

2025/05/29

New color additive

CAP 0C0317

Jagua Blue (Genipin-Glycine)

2020

2023/11/03

2024/01/23

New color additive

CAP 0C0316

Spirulina Extract

2020

2022/11/10

2025/05/16

Expansion of use

CAP 0C0318

Calcium Carbonate

2020

2022/09/27

2023/01/24

Expansion of use

CAP 5C0303

Antarctic Krill Meal

2018

2022/05/10

2022/09/07

New color additive (animal feed)

CAP 8C0313

Butterfly Pea Flower Extract

2018

2021/09/02

2021/12/29

New color additive

CAP 8C0312

Silver Nitrate

2018

2021/10/06

2021/12/29

New color additive (cosmetics)

A list of FAP/CAPs currently under review or held in abeyance can be searched in FDA's official database, Food Additive and Color Additive Petitions Under Review or Held in Abeyance.

8. CIRS One-Stop Color Additive Petition Services

With extensive experience in food regulatory compliance, CIRS Group provides global companies with comprehensive support throughout the CAP process, including:

  • Data gap analysis: Review existing manufacturing processes, product specifications, and toxicological data, and prepare a gap analysis report and customized checklist.
  • FDA pre-submission consultation: Assist in preparing consultation materials and organizing pre-submission discussions with FDA under 21 CFR 70.42(c) to confirm the appropriateness of proposed studies and the adequacy of supporting data.
  • Study coordination: Coordinate with laboratories capable of conducting studies in compliance with GLP requirements and develop toxicological study protocols with reference to FDA's Redbook and applicable OECD guidelines.
  • Dossier preparation and submission: Prepare the complete petition package in accordance with 21 CFR 71.1(c) and assist with submission using Form FDA 3503.
  • Regulatory review support: Track FDA questions throughout the review process, coordinate supplemental data and responses, and support the project through publication of the final rule and codification in the CFR.
  • Extended services: Support environmental assessments under NEPA and provide strategic advice for parallel regulatory submissions in China, including applications for new food additive varieties.

If you have a natural or synthetic color additive intended for the U.S. market, please do not be hesitate to contact our expert or get in touch with us via service@cirs-group.com.

Why Choose CIRS?

Established in 2007, the CIRS Group is a leading product safety and regulatory consulting firm. CIRS has branch offices in the Republic of Ireland, South Korea, the United States, the United Kingdom, Japan, and China. CIRS Group utilizes its technical expertise, various resources, and international network to provide one-stop compliance services from regulatory compliance, laboratory testing, and R&D to data services across multiple industries. This includes chemicals, cosmetics, food and food beverages, medical devices, agrochemical products, disinfectants, and consumer goods. It helps clients gain a competitive advantage by reducing business risks associated with regulatory affairs.

The vast majority of members in CIRS Food Business Division have over 10 years of professional experience in food compliance, with more than 80% holding Master’s or Doctoral degrees in food-related disciplines. The CIRS toxicology expert team consists of 24 Chinese Certified Toxicologists (DCST), 2 American Board Certified Toxicologists (DABT), and 2 European Registered Toxicologists (ERT). CIRS has provided one-stop food compliance services to over 1,000 domestic and international food and related enterprises. 

Previous: None